TY - JOUR
KW - Adult
KW - Appalachian Region/epidemiology
KW - Birth Weight/drug effects
KW - Buprenorphine, Naloxone Drug Combination/adverse effects/therapeutic use
KW - Female
KW - Humans
KW - Infant, Newborn
KW - Methadone/therapeutic use
KW - Neonatal Abstinence Syndrome/epidemiology/therapy
KW - Opiate Substitution Treatment/methods/statistics & numerical data
KW - Opioid-Related Disorders/drug therapy/epidemiology/psychology
KW - Pregnancy
KW - Pregnancy Complications/drug therapy/epidemiology/psychology
KW - Pregnant Women/psychology
KW - Retrospective Studies
KW - risk adjustment
AU - L. Nguyen
AU - L. R. Lander
AU - K. E. O'Grady
AU - P. J. Marshalek
AU - A. Schmidt
AU - A. K. Kelly
AU - H. E. Jones
A1 - 
BT - The American journal on addictions
C5 - Opioids & Substance Use; Healthcare Disparities
CP - 2
CY - England
DO - 10.1111/ajad.12687
IS - 2
JF - The American journal on addictions
PB - American Academy of Addiction Psychiatry
PP - England
PY - 2018
SN - 1521-0391; 1055-0496
SP - 92
EP - 96
EP - 
T1 - Treating women with opioid use disorder during pregnancy in Appalachia: Initial neonatal outcomes following buprenorphine + naloxone exposure
T2 - The American journal on addictions
TI - Treating women with opioid use disorder during pregnancy in Appalachia: Initial neonatal outcomes following buprenorphine + naloxone exposure
U1 - Opioids & Substance Use; Healthcare Disparities
U2 - 29473258
U3 - 10.1111/ajad.12687
VL - 27
VO - 1521-0391; 1055-0496
Y1 - 2018
ER -